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Introduction   
   
P63 gene is the member of p53 gene family,  found by Young in 1998 (1).
 
 It was found 
that the gene is located in 3q27-29 chromosome and according to presence or 
absence of a transcriptional activation domain, has a  six isoformes, named α, β, γ  
subdivided into a two groups;  TA p63 and ΔNp 63, characterized by different 
transactivation potentials and biologic properties (1-8). 
 
It was expected, that due the belongs to the familly,  p63 gene behaves resembling 
the  p53 as the tumor supressor gene. However, further investigations have shown 
that only one group of the  TAp63 isoformes demonstrate similarity to p53 (1-8). 
 
TAp63 induces apoptosis and mediate cell cycle control by transactivation of p53 
target gene, while  ΔNp63 behaves dominantly negative, blocking both the activity of 
TAp63 and  p53, inducing a cell proliferation (1-3,5,9).
 
By this way ΔNp63 behaves as 
an oncogene, which has been confirmed by various studies, where different kinds of 
squamous cell carcinomas and oral precancerous lesions have shown an 
overexpression of  the ΔNp63  isoformes (2,4,7-16). 
 
Except carcinogenesis, p63 isoformes play more important roles in ectodermal 
differentiation during embryogenesis, stem cell biology, proliferation of craniofacial 
structures and epithelial development (2,5,9,11,17-22).
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Abstract      
                         
Objective: The purpose of the study was to examine the expression of p63  in asymptomatic 
enclosed lower third molar covering oral mucosa.  
 Design:  :  50 samples of normal oral mucosa taken from 50 patients  who underwent third 
molar surgery were included into the study. The samples were subdivided into two groups. 
One group was made of oral mucosa covering completely impacted teeth, while other group 
was made of oral mucosa  covering partially impacted teeth. 
Only nuclear staining of the cells was evaluated by percentage of positive cells. 
Results: : Immunoexpression of p63 was almost equal in submucosa cells of both groups, 
showing a faint to intermediate positivity. Basal layer of oral mucosa covering completely  
enclosed teeth have shown a stronger expression of p63 than it was the case with the other 
group.  
Conclusion: Expression of p63 is noticed in basal and suprabasal layers of oral mucosa 
covering impacted teeth. Weak expression of p63 in basal layer of oral mucosa covering 
partially impacted teeth, migh be associated with teeth eruption, lesser number of stem cells 
and thinner  mucosa patch than it is a case with oral mucosa covering completely impacted 
teeth.  
 
KEYWORDS:  p63,  immunohistochemistry, oral mucosa,  impacted teeth, stem cells.  
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Transcriptionally the most active p63 isoformes are the γ 
isoformes, while α isoformes contain protein-protein 
interaction domain known as a sterile alpha motif (SAM), 
which is  involved in developmental processes (5,6,17).
 
 It 
is found that in some congenital syndromes such are 
ankyloblepharon ectodermal dysplasia and clefting 
syndrome (AEC or Hay-Wells syndrome) and limb-
mammary syndrome (LMS) the  SAM  domain is mutated 
(5,17).   
Under normal conditions,  p63 is expressed in select 
epithelial cells of the tissues such as embryonic 
ectoderm, skin, breast myoepithelium, oral epithelium, 
prostat and urethra (2,5,11,13,18). It is also shown that 
p63 is involved in maintance of epidermal stem cells and 
stratification of the epidermis (18-22). 
In last decade, the p63 gene was a subject of different 
immunohistochemical studies, which included normal 
oral mucosa and pathological changes associated with it 
(4,7-16). 
 
As we know third molar surgery is one of the most 
performed procedures in dentistry, characterized by 
extraction of impacted tooth with curettage of dental 
follicular and pericoronary tissues. Due the results of our 
previous study in which, we have investigated 
pathological changes and  immunoexpressivity of  p63  
in dental follicles of asymptomatic partially and 
completely impacted lower third molars (22), the aim of 
this study is to analyze the immunoexpressivity of  p63  
in the oral  mucosa covering  these teeth.  
 
MATERIALS AND METHODS 
  
The study was approved by the Istanbul University Ethics 
Committe for Scientific Research in humans.  
Cases selection 
 Fifty patients (25 male, 25 female), age range from 18 to 
35 years, with partially or completelly impacted 
asymptomatic lower third molars were included into the 
study. All of the patients were medically healthy  non 
smokers and were not taking any drugs at least for two 
months before surgery.  
Twenty-five teeth were fully covered by mucosa and 
bone (completely impacted), while 25 teeth were 
partially covered with bone and mucosa (partially 
impacted). All surgeries were performed by the same 
surgeon and under local anesthesia, in the normal course 
of practice and similar conditions. During the surgery, 
approximately 2x3mm of covering mucosa tissue sample, 
taken from the horizontal portion of the incision was 
excised, immediately fixed in 10% paraformaldehide and 
after that embedded in parafin, which was cut into 5 µm 
section by a rotary microtome. From every specimen 2 
preparations were made (one preparation was stained 
with hematoxylin-eosin, while the other preparation was 
prepared for immunostaining for p63). 
 
Immunohistochemical analysis 
Immunohistochemical (IHC) staining of the sections were 
carried out by streptavidin-biotin peroxidase method 
using p63 antibody (Gene Tex, Inc, San Antonio, USA).  
Briefly, 5 micrometer sections were deparaffinized and 
hydrated through graded alcohols to water. The slides 
were immersed in citrate buffer in a microwave oven for 
antigen retrieval for 20 min (5min.x4). After cooling for 
20 min and washing in PBS (phosphate buffer saline) for 
5 min, endogen peroxidase was blocked with %3 
hydrogen peroxidase and then washing in PBS for 15 
min. the slides were incubated with block solution for 15 
min. Afterward the sildes were incubated with primary 
antibodies for 30 min., and then washed and incubated 
with linking reagent for 25 min, the slides were 
incubated streptavidin-biotin solution for 25 min. 
Staining was visualized using AEC chromogen. Mayer 
hematoxylin was used as a counterstain.  
IHC staining was evaluated as percentage of positive 
stained cells and the intensity of the stain according to 
following criteria:  negative nuclear staining (0), when the 
stained cells were comprised from 0 to < 10%;  faint  
positivity (1+), when the stained cells were comprised 
from 10 to < 30%;  intermediate positivity (2+), when the 
stained cells were comprised from 30 to < 60%;  and 
strong positivity (3+), when the stained cells were 
comprised from > 60%.  
 
Data were analysed using SPSS INC; Chicago USA 
version 16.  and significant differences (95% or P < 0.05), 
between groups were determined using Kruskal-Wallis 
test. 
 
 
RESULTS 
 
Fifty samples subdivided into  two equal groups, of 
masticatory mucosa covering completely and partially 
impacted lower third molars, were 
immunohistochemically examined for expression to p63. 
Positive nuclear reaction was noticed in basal and 
suprabasal layers of  both  groups. 
Analyzing the expression of p63 in basal layer of mucosa, 
in the group of completely impacted teeth; 1 (4%) 
specimen showed negative nuclear staining, 9 (36%) 
specimens  faint, 9 (36%) intermediate and 6 (24%) 
specimens showed strong  nuclear positivity. (Figure 1. 
and Figure 2.)  The  results of another group showed 16 
(64%) samples with faint and 9 (36%) samples with 
intermediate nuclear positivity.  
( Figure 3) No sample from this group showed a negative 
or strong positivity.  
P63 immunoexpressivity was almost the same in 
suprabasal layers of mucosa from the both groups . In 
the group with completely impacted teeth 2 (8%) 
samples did not showed nuclear staining for p63 and a 
number of samples with the same results from another 
group was 5 (20%). Faint positivity was noticed in 21 
(84%) of mucosa samples from the group of completely 
impacted and 19 (76%) of partially impacted teeth, 
whereas intermediate positivity for p63 was present in 2 
(8%) mucosa samples taken from the group of 
completely impacted teeth and 1 (4%) from partially  
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 Figure -1 Immunohistochemical stain of oral mucosa 
covering completely impacted teeth with intermediate 
(2+) nuclear positivity (p63 x 200). 
 
Figure -2 Immunohistochemical stain of oral mucosa 
covering completely  impacted teeth with strong 
(3+) nuclear positivity ( p63 x 200). 
 
Figure -3 Immunohistochemical stain of oral mucosa 
covering partially  impacted teeth with faint (1+) 
nuclear positivity (p63 x 400). 
 
Table -1 Statistical  analysis  of p63 expression in oral mucosa covering completely and partially impacted teeth. 
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impacted teeth. No sample from the both groups did 
show a strong nuclear positivity. (Table 1) 
Comparing the results from the both groups, it is noticed 
that immunoexpressivity of p63 is almost the same in 
suprabasal layers (P=1). Although basal layers  from the 
group of completelly impacted teeth show a stronger 
immunoexpressivity to p63, the results are not 
statistically significant (P= 0.89). 
  
 
DISCUSSION 
 
From the last decade, in oral and maxillofacial surgery, 
the p63 gene is  one of the most investigated subjects.  
Studies by different authors have deal with a role of p63 
from the stem cell biology and developemental 
processes of teeth formations to carcinogenesis (4,5,7-
16,20-22).
 
 In one of our previous studies we were examinated 
pathological changes and immunoexpressivity of p63  in 
dental follicles of asymptomatic impacted lower third 
molars (22). We found out that  the immunoexpressivity 
for p63 was stronger in the dental follicles of the  group 
with completely impacted teeth, than it was a case  of 
dental follicles of  the group with partially impacted 
teeth, and concluded that these results might be 
associated with the follicular stem cells (22).  From the 
same patients, we were in this study analized the 
expression of p63 in the mucosa samples, where 
immunoexpression for p63 was noticed in basal and 
suprabasal layer of both group of samples.  
 Studies made by the other authors  have also shown the 
expression of  p63 in basal and suprabasal layers of 
normal oral epithelium (4,8-10,12,15).  A results from a 
study of  Lo Muzio et al.(4) have shown a high p63 
expression in the cells of basal and parabasal  layers of 
oral epithelium, comparing the results with oral 
squamous cell carcininoma samples. The author 
concluded that the p63 overexpression in oral 
carcinogenesis is one of indicators of the ability of oral 
cancer cells to proliferate and stay undifferentiated (4). 
With the similar results Nylander et al.(9) and De Oliviera 
et al.(10)  analyzing  the expression of p63 in different 
tissues including oral mucosa and squamous cell 
carcinomas were disposed .  A results from Bortoluzzi et 
al(8). have shown the presence of p63 
immunoexpressivity in basal, parabasal and suprabasal 
layers of healthy oral mucosa, as same as the strong 
expression in oral squamous cell carcinomas and oral 
dysplasia.  Chen et al.(12,15) in two different studies,  
have shown that  TAp63 and ΔNp63  isoformes are 
present in basal and suprabasal layers of buccal mucosa, 
also with predominant expression of ΔNp63  isoforme in  
primary well-differentiated buccal carcinoma and oral 
epithelial dysplasia, confirming once more an 
oncogenetic  role of p63 isoformes.  However, ΔNp63 
isoformes are not overexpressed only in cancer cells. 
Basal cells of normal human epithelium show a strong 
expression of ΔNp (especially α isoforme), which 
overexpression blocks keratinocyte differentiation. Soon 
as the cell withdraw from the stem cell section and  
become differentiated, the  ΔNpα expression is lost 
(13,14,17,18). Some authors suggests that for these 
reasons, p63 can be a marker for keratinocyte stem cells  
and its expression may be more related to stem cells 
maintenance and cell differentiation, than tumorogenesis 
(8,18,21).
 
Findings from Hatakeyama et al.(20)  about 
expression of p63 in the oral gingival epithelium,  
resulted with conclusion that basal layer of oral gingival 
epithelium contain stem cells, which may play an 
essential role in the supply of gingival epithelial cells. 
In our study using for immunohistochemistry a primary 
antibody which recognize all isoformes of p63, the 
expression was stronger in basal layer of mucosa 
covering completely impacted teeth, than it was a case 
with basal layer of mucosa covering partially impacted 
teeth. However, the results from Table 1. suggests that 
the larger number of oral mucosa samples from both 
groups, would give more statistically significant results, 
than we have observed (P= 0.89). In mukosa suprabasal 
layers from the both groups, expression for p63 was 
almost the same (P=1). 
In the English literature we did not found similar studies 
to  our, because of we could not discuss about potential 
influence of tooth eruption to the stem cells of the 
covering mucosa and expression of the p63 associated 
with it. We are in opinion that although statistically not 
significant, expression of p63 in basal layers of the 
mucosa covering partially impacted teeth might be 
associated with teeth eruption, lesser number of 
keratinocyt stem cells and thinner  mucosa patch, than it 
is a case with oral mucosa covering completely impacted 
teeth.  
Also we hope, that  other researchers with their studies 
will supplement our investigations. 
REFERENCES 
1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming M D, 
Dotsch V et al.  P63, a p53 homolog at 3q27–29, encodes 
multiple products with transactivating, death-inducing, 
and dominant-negative activities. Mol. Cell 2 (1998), pp. 
305–316. 
 
2.  Moll UM, Slade N. P63 and p73: roles in development 
and tumor formation. Mol Cancer Res. 2(7) (2004), pp. 
371-386. 
 
3.  Little NA, Jochemsen AG. P63. Int J Biochem Cell Biol. 
34(1) (2002), pp. 6-9. 
 
4.  Lo Muzio L, Campisi G, Farina A, Rubini C, Pastore L, 
Giannone N et al. Effect of p63 expression on survival in 
oral squamous cell carcinoma. Cancer Invest.25(6) (2007), 
pp. 464-469. 
 
17 
   IJCDS • MAY, 2011 • 2(2) © 2011  Int. Journal of Clinical Dental Science 
5. Laurikala J. Molecular Mechanisms of Ectodermal 
Dysplasia Syndromes (academic dissertation). Helsinki, 
Finland: Faculty of Medicine of the University of Helsinki. 
(2004), pp. 19-23. 
 
6. Antonini D, Rossi B, Han R, Minichiello A, Di Palma T, 
Corrado M et al. An autoregulatory loop directs the 
tissue-specific expression of p63 through a long-range 
evolutionarily conserved enhancer. Mol Cell Biol. 26(8) 
(2006), pp. 3308-3318. 
 
7. Bidaud P, Chasle J, Sichel F, Rousseau S, Petit P, Pottier 
D et al. Expression of p53 family members and CD44 in 
oral squamous cell carcinoma (OSCC) in relation to 
tumorigenesis. Histol Histopathol. 25(3) (2010), pp. 331-
339. 
 
8.  Bortoluzzi MC, Yurgel LS, Dekker NP, Jordan RC, 
Regezi JA. Assessment of p63 expression in oral 
squamous cell carcinomas and dysplasias. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod. 98(6) (2004), pp.698-
704. 
9. Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, 
Zhanxiang W et al. Differential expression of p63 
isoforms in normal tissues and neoplastic cells. J Pathol. 
198(4) (2002) pp. 417-427. 
10. de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic 
impact of p53 and p63 immunoexpression in oral 
squamous cell carcinoma. J Oral Pathol Med. 36(4) 
(2007), pp.191-197. 
11. Westfall MD, Pietenpol JA. P63: Molecular complexity 
in development and cancer. Carcinogenesis. 25(6) (2004), 
pp.857-864. 
12. Chen YK, Hsue SS, Lin LM. Expression of p63 protein 
and mRNA in oral epithelial dysplasia. J Oral Pathol Med. 
34(4) (2005), pp. 232-239. 
 
13. Parsa R, Yang A, McKeon F, Green H. Association of 
p63 with proliferative potential in normal and neoplastic 
human keratinocytes. J Invest Dermatol 113 (1999), pp. 
1099-1105. 
 
14.  Nylander K, Coates PJ, Hall PA. Characterization of 
the expression patternof p63a and DNp63a in benign 
and malignant oral epithelial lesions. Int J Cancer 87 
(2000), pp. 368-372. 
 
15.  Chen YK, Hsue SS, Lin LM. Expression of p63 (TA and 
deltaN isoforms) in human primary well differentiated 
buccal carcinomas. Int J Oral Maxillofac Surg. 33(5) 
(2004), pp. 493-497. 
16. Haniffa AM, Saitoh M, Abiko Y, Takeshima M, 
Nishimura M, Yamazaki M et al. Expression pattern of 
p63 in oral epithelial lesions and submucous fibrosis 
associated with betel-quid chewing in Sri Lanka. Med 
Mol Morphol. 40(4) (2007), pp.203-207.  
17. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The 
DNp63a phosphoprotein binds the p21 and 14-3-3j 
promoters in vivo and has transcriptional repressor 
activity that is reduced by Hay-Wells syndrome-derived 
mutations. Mol Cell Biol 23 (2003), pp. 2264-2276. 
 
18.  Pellegrini G, Dellambra E, Golisano O, Martinelli E, 
Fantozzi I, Bondanza S et al. P63 identifies keratinocyte 
stem cells. Proc Natl Acad Sci USA 98(6) (2001), pp. 
3156-3161. 
19. King KE, Ponnamperuma RM, Gerdes MJ, Tokino T, 
Yamashita T, Baker CC, Weinberg WC. Unique domain 
functions of p63 isotypes that differentially regulate 
distinct aspects of epidermal homeostasis. 
Carcinogenesis. 27(1) (2006), pp. 53-63.  
20. Hatakeyama S, Yaegashi T, Takeda Y, Kunimatsu K. 
Localization of bromodeoxyuridine-incorporating, p63- 
and p75(NGFR)- expressing cells in the human gingival 
epithelium. J Oral Sci. 49(4) (2007), pp. 287-291. 
21.  Tao Q, Qiao B, Lv B, Zheng C, Chen Z, Huang H. p63 
and its isoforms as markers of rat oral mucosa epidermal 
stem cells in vitro. Cell Biochem Funct. 27(8) (2009), pp. 
535-541. 
22. Brkić A, Mutlu S, Koçak-Berberoğlu H, Olgaç V. 
Pathological changes and immunoexpression of p63 
gene in dental follicles of asymptomatic impacted lower 
third molars: an immunohistochemical study. J Craniofac 
Surg. 21(3) (2010), pp. 854-857. 
 
 
 
 
 
 
 
 
 
 
 
18 
  
 
 
 
 
 
 
 
 
 
